Nick Pellow

Nick Pellow is an associate in Goodwin’s Antitrust and Competition practice. He started at the firm in 2022. Nick concentrates his legal practice in representing corporate entities regarding competition regulation before federal antitrust authorities.

In addition to his billable work, Nick participates in immigration asylum matters on a pro bono basis. He previously helped secure a favorable settlement in a major impact litigation case over education rights in the state of New York.

Nick’s recent representative experience includes:

• Akili, Inc. in its acquisition by Virtual Therapeutics
• Pathology Watch in its acquisition by Sonic Healthcare Limited for $130 million
• Bobbie in its acquisition of Nature’s One
• iRobot Corporation in its proposed acquisition by Amazon.com, Inc. for approximately $1.7 billion
• Frazier Healthcare Partners in its sale of Parata Systems to Becton Dickinson & Co. for $1.525 billion
• CPS Solutions in its acquisition of Trellis Rx

Prior to joining Goodwin, Nick worked in the New York office of another major international law firm.

Nick is a contributor to Goodwin’s Antitrust Trends in Technology, Life Sciences, and Healthcare series, which provides quarterly analysis and commentary on antitrust developments. Nick’s publications also include an article in Concurrences, an independent legal publisher dedicated to antitrust law and competition economics, summarizing anticipated policy developments in antitrust regulation of bank mergers.

• Co-Author, “Tech’s Impact On Financial Services Competition,” Concurrences, November 2021